Estetrol Prevents Hot Flushes and Improves Quality of Life in Patients with Advanced Prostate Cancer Treated with Androgen Deprivation Therapy: The PCombi Study

Autor: Yvette, Zimmerman, Mark, Frydenberg, Hendrik, van Poppel, R Jeroen A, van Moorselaar, Erik P M, Roos, Diederik M, Somford, Ton A, Roeleveld, Tjard D, de Haan, Harm H E, van Melick, Yacov, Reisman, Jan, Krijgh, Frans M J, Debruyne, Herjan J T, Coelingh Bennink

Publikováno v: European Urology Open Science, 45, 59-67. Elsevier BV
Zimmerman, Y, Frydenberg, M, van Poppel, H, van Moorselaar, R J A, Roos, E P M, Somford, D M, Roeleveld, T A, de Haan, T D, van Melick, H H E, Reisman, Y, Krijgh, J, Debruyne, F M J & Coelingh Bennink, H J T 2022, ' Estetrol Prevents Hot Flushes and Improves Quality of Life in Patients with Advanced Prostate Cancer Treated with Androgen Deprivation Therapy : The PCombi Study ', European Urology Open Science, vol. 45, pp. 59-67 . https://doi.org/10.1016/j.euros.2022.09.006

BACKGROUND: Androgen deprivation therapy (ADT) for prostate cancer (PCa) is accompanied by side effects affecting health-related quality of life (HRQL). OBJECTIVE: To assess the effects of the fetal estrogen estetrol (E4) on symptoms related to estro

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d41742ff006a0173ef57e6cc4c06df02
https://research.vumc.nl/en/publications/b9adeebb-3256-4593-a656-09a9a1caa278

The AVOCAT study: Bicalutamide monotherapy versus combined bicalutamide plus dutasteride therapy for patients with locally advanced or metastatic carcinoma of the prostate-a long-term follow-up comparison and quality of life analysis

Autor: Peter F.A. Mulders, Henk Vergunst, Jos L. Bruins, G.A.H.J. Smits, Siebren Dijkstra, Wim P.J. Witjes, Peter L. M. Vijverberg, Erik P. M. Roos, Arno D. H. Geboers

Publikováno v: SpringerPlus
Springerplus, 5, 653-653
Springerplus, 5, pp. 653-653

Contains fulltext : 170222.pdf (Publisher’s version ) (Open Access) PURPOSE: Compare the efficacy and tolerability of dutasteride in combination with bicalutamide to bicalutamide monotherapy in the treatment of locally advanced and metastatic prost

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b09a21de249f84c1deb62815f901afc9
https://hdl.handle.net/2066/170222

Researcher from Antonius Hospital Reports Details of New Studies and Findings in the Area of Prostate Cancer (Estetrol Inhibits the Prostate Cancer Tumor Stimulators FSH and IGF-1).

Publikováno v: Clinical Oncology Week; 10/29/2024, p1032-1032, 1p